HEADER TRANSFERASE 19-JAN-09 3FWQ TITLE INACTIVE CONFORMATION OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE II SUBUNIT ALPHA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CK II; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PT7-7 KEYWDS CASEIN KINASE 2, PROTEIN KINASE CK2, EUKARYOTIC PROTEIN KINASES, KEYWDS 2 INACTIVE CONFORMATION, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, KEYWDS 3 PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, WNT KEYWDS 4 SIGNALING PATHWAY EXPDTA X-RAY DIFFRACTION AUTHOR K.NIEFIND,J.RAAF,O.G.ISSINGER REVDAT 5 01-NOV-23 3FWQ 1 REMARK REVDAT 4 04-APR-12 3FWQ 1 JRNL REVDAT 3 13-JUL-11 3FWQ 1 VERSN REVDAT 2 31-MAR-09 3FWQ 1 JRNL REVDAT 1 17-FEB-09 3FWQ 0 JRNL AUTH J.RAAF,O.G.ISSINGER,K.NIEFIND JRNL TITL FIRST INACTIVE CONFORMATION OF CK2 ALPHA, THE CATALYTIC JRNL TITL 2 SUBUNIT OF PROTEIN KINASE CK2 JRNL REF J.MOL.BIOL. V. 386 1212 2009 JRNL REFN ISSN 0022-2836 JRNL PMID 19361447 JRNL DOI 10.1016/J.JMB.2009.01.033 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.NIEFIND,B.GUERRA,L.A.PINNA,O.G.ISSINGER,D.SCHOMBURG REMARK 1 TITL CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE REMARK 1 TITL 2 CK2 FROM ZEA MAYS AT 2.1 A RESOLUTION REMARK 1 REF EMBO J. V. 17 2451 1998 REMARK 1 REFN ISSN 0261-4189 REMARK 1 PMID 9564028 REMARK 1 DOI 10.1093/EMBOJ/17.9.2451 REMARK 1 REFERENCE 2 REMARK 1 AUTH K.NIEFIND,M.PUTTER,B.GUERRA,O.G.ISSINGER,D.SCHOMBURG REMARK 1 TITL GTP PLUS WATER MIMIC ATP IN THE ACTIVE SITE OF PROTEIN REMARK 1 TITL 2 KINASE CK2 REMARK 1 REF NAT.STRUCT.BIOL. V. 6 1100 1999 REMARK 1 REFN ISSN 1072-8368 REMARK 1 PMID 10581548 REMARK 1 DOI 10.1038/70033 REMARK 1 REFERENCE 3 REMARK 1 AUTH K.NIEFIND,B.GUERRA,I.ERMAKOWA,O.G.ISSINGER REMARK 1 TITL CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2: INSIGHTS INTO REMARK 1 TITL 2 BASIC PROPERTIES OF THE CK2 HOLOENZYME REMARK 1 REF EMBO J. V. 20 5320 2001 REMARK 1 REFN ISSN 0261-4189 REMARK 1 PMID 11574463 REMARK 1 DOI 10.1093/EMBOJ/20.19.5320 REMARK 1 REFERENCE 4 REMARK 1 AUTH I.ERMAKOVA,B.BOLDYREFF,O.G.ISSINGER,K.NIEFIND REMARK 1 TITL CRYSTAL STRUCTURE OF A C-TERMINAL DELETION MUTANT OF HUMAN REMARK 1 TITL 2 PROTEIN KINASE CK2 CATALYTIC SUBUNIT REMARK 1 REF J.MOL.BIOL. V. 330 925 2003 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 12860116 REMARK 1 REFERENCE 5 REMARK 1 AUTH C.W.YDE,I.ERMAKOVA,O.G.ISSINGER,K.NIEFIND REMARK 1 TITL INCLINING THE PURINE BASE BINDING PLANE IN PROTEIN KINASE REMARK 1 TITL 2 CK2 BY EXCHANGING THE FLANKING SIDE-CHAINS GENERATES A REMARK 1 TITL 3 PREFERENCE FOR ATP AS A COSUBSTRATE REMARK 1 REF J.MOL.BIOL. V. 347 399 2005 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 15740749 REMARK 1 DOI 10.1016/J.JMB.2005.01.003 REMARK 1 REFERENCE 6 REMARK 1 AUTH K.NIEFIND,O.G.ISSINGER REMARK 1 TITL PRIMARY AND SECONDARY INTERACTIONS BETWEEN CK2ALPHA AND REMARK 1 TITL 2 CK2BETA LEAD TO RING-LIKE STRUCTURES IN THE CRYSTALS OF THE REMARK 1 TITL 3 CK2 HOLOENZYME REMARK 1 REF MOL.CELL.BIOCHEM. V. 274 3 2005 REMARK 1 REFN ISSN 0300-8177 REMARK 1 PMID 16335523 REMARK 1 REFERENCE 7 REMARK 1 AUTH K.NIEFIND,C.W.YDE,I.ERMAKOVA,O.G.ISSINGER REMARK 1 TITL EVOLVED TO BE ACTIVE: SULFATE IONS DEFINE SUBSTRATE REMARK 1 TITL 2 RECOGNITION SITES OF CK2ALPHA AND EMPHASISE ITS EXCEPTIONAL REMARK 1 TITL 3 ROLE WITHIN THE CMGC FAMILY OF EUKARYOTIC PROTEIN KINASES REMARK 1 REF J.MOL.BIOL. V. 370 427 2007 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 17524418 REMARK 1 DOI 10.1016/J.JMB.2007.04.068 REMARK 1 REFERENCE 8 REMARK 1 AUTH J.RAAF,K.KLOPFFLEISCH,O.G.ISSINGER,K.NIEFIND REMARK 1 TITL THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2 REMARK 1 TITL 2 STRUCTURALLY DEVIATES FROM ITS MAIZE HOMOLOGUE IN COMPLEX REMARK 1 TITL 3 WITH THE NUCLEOTIDE COMPETITIVE INHIBITOR EMODIN REMARK 1 REF J.MOL.BIOL. V. 377 1 2008 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 18242640 REMARK 1 DOI 10.1016/J.JMB.2008.01.008 REMARK 1 REFERENCE 9 REMARK 1 AUTH J.RAAF,E.BRUNSTEIN,O.G.ISSINGER,K.NIEFIND REMARK 1 TITL THE CK2 ALPHA/CK2 BETA INTERFACE OF HUMAN PROTEIN KINASE CK2 REMARK 1 TITL 2 HARBORS A BINDING POCKET FOR SMALL MOLECULES REMARK 1 REF CHEM.BIOL. V. 15 111 2008 REMARK 1 REFN ISSN 1074-5521 REMARK 1 PMID 18291315 REMARK 1 DOI 10.1016/J.CHEMBIOL.2007.12.012 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0063 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.30 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 3 NUMBER OF REFLECTIONS : 25746 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.173 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.233 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.600 REMARK 3 FREE R VALUE TEST SET COUNT : 1253 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1877 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.59 REMARK 3 BIN R VALUE (WORKING SET) : 0.2050 REMARK 3 BIN FREE R VALUE SET COUNT : 105 REMARK 3 BIN FREE R VALUE : 0.3240 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5634 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 204 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 47.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.15 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.87000 REMARK 3 B22 (A**2) : 7.87000 REMARK 3 B33 (A**2) : -15.73000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.136 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.056 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.144 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 13.697 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.966 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.934 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5803 ; 0.006 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7841 ; 0.885 ; 1.949 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 666 ; 4.734 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 314 ;33.377 ;23.057 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1028 ;15.173 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 52 ;15.562 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 810 ; 0.064 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4478 ; 0.003 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3338 ; 1.612 ; 6.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5422 ; 2.556 ; 9.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2465 ; 1.558 ; 6.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2419 ; 2.175 ; 9.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TWIN DETAILS REMARK 3 NUMBER OF TWIN DOMAINS : 2 REMARK 3 TWIN DOMAIN : 1 REMARK 3 TWIN OPERATOR : H,K,L REMARK 3 TWIN FRACTION : 0.501 REMARK 3 TWIN DOMAIN : 2 REMARK 3 TWIN OPERATOR : -H,K,-L REMARK 3 TWIN FRACTION : 0.499 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 2 A 12 REMARK 3 RESIDUE RANGE : A 117 A 335 REMARK 3 ORIGIN FOR THE GROUP (A): -15.8900 27.5700 2.6680 REMARK 3 T TENSOR REMARK 3 T11: 0.0499 T22: 0.0518 REMARK 3 T33: 0.0196 T12: -0.0070 REMARK 3 T13: 0.0098 T23: -0.0148 REMARK 3 L TENSOR REMARK 3 L11: 0.8730 L22: 1.3292 REMARK 3 L33: 0.9825 L12: 0.0014 REMARK 3 L13: -0.6826 L23: -0.0673 REMARK 3 S TENSOR REMARK 3 S11: 0.0039 S12: -0.0724 S13: 0.0694 REMARK 3 S21: 0.1299 S22: 0.0178 S23: 0.1136 REMARK 3 S31: 0.0329 S32: -0.0781 S33: -0.0216 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 13 A 116 REMARK 3 ORIGIN FOR THE GROUP (A): 4.7460 13.8960 -5.0660 REMARK 3 T TENSOR REMARK 3 T11: 0.1185 T22: 0.1065 REMARK 3 T33: 0.0553 T12: 0.0385 REMARK 3 T13: 0.0199 T23: 0.0062 REMARK 3 L TENSOR REMARK 3 L11: 2.0347 L22: 0.3190 REMARK 3 L33: 1.4053 L12: -0.2869 REMARK 3 L13: 1.3250 L23: -0.5075 REMARK 3 S TENSOR REMARK 3 S11: 0.0176 S12: -0.0594 S13: -0.2341 REMARK 3 S21: -0.0541 S22: 0.0248 S23: -0.0553 REMARK 3 S31: 0.1746 S32: 0.0641 S33: -0.0425 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 2 B 12 REMARK 3 RESIDUE RANGE : B 117 B 335 REMARK 3 ORIGIN FOR THE GROUP (A): 8.1280 51.5830 -18.0880 REMARK 3 T TENSOR REMARK 3 T11: 0.0553 T22: 0.0525 REMARK 3 T33: 0.0230 T12: 0.0028 REMARK 3 T13: -0.0115 T23: 0.0063 REMARK 3 L TENSOR REMARK 3 L11: 1.2325 L22: 0.6973 REMARK 3 L33: 1.0652 L12: -0.1043 REMARK 3 L13: -0.0196 L23: -0.6262 REMARK 3 S TENSOR REMARK 3 S11: 0.0290 S12: 0.1119 S13: 0.1410 REMARK 3 S21: -0.0633 S22: -0.0201 S23: 0.0335 REMARK 3 S31: -0.0950 S32: 0.0306 S33: -0.0090 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 13 B 116 REMARK 3 ORIGIN FOR THE GROUP (A): 21.8610 30.9710 -10.3320 REMARK 3 T TENSOR REMARK 3 T11: 0.1362 T22: 0.1449 REMARK 3 T33: 0.1028 T12: 0.0377 REMARK 3 T13: 0.0171 T23: 0.0185 REMARK 3 L TENSOR REMARK 3 L11: 0.4800 L22: 1.3336 REMARK 3 L33: 1.2440 L12: -0.3717 REMARK 3 L13: -0.4417 L23: 1.2130 REMARK 3 S TENSOR REMARK 3 S11: 0.0612 S12: -0.0351 S13: -0.0673 REMARK 3 S21: -0.0362 S22: 0.0884 S23: -0.2434 REMARK 3 S31: 0.0504 S32: 0.1833 S33: -0.1496 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3FWQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 27-JAN-09. REMARK 100 THE DEPOSITION ID IS D_1000051137. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-FEB-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X12 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95370 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26999 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 34.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 200 DATA REDUNDANCY : 7.700 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : 0.10000 REMARK 200 FOR THE DATA SET : 17.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 7.20 REMARK 200 R MERGE FOR SHELL (I) : 0.72400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2PVR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.33 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN STOCK SOLUTION: 10MG/ML REMARK 280 CK2ALPHA, 500MM SODIUM CHLORIDE, 25MM TRIS/HCL, PH 8.5; REMARK 280 RESERVOIR: 2M AMMONIUM SULFATE, 2M SODIUM CHLORIDE; DROP: REMARK 280 0.001ML RESERVOIR SOLUTION, 0.001ML PROTEIN STOCK SOLUTION, REMARK 280 0.003ML 1MM AMPPNP, 0.0006ML 10MM MAGNESIUM CHLORIDE, 0.0001ML REMARK 280 GLYCEROL, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+3/4 REMARK 290 4555 Y,-X,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 62.84050 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 94.26075 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 31.42025 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 MET B 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 37 1.63 -68.39 REMARK 500 ASN A 62 -11.35 66.37 REMARK 500 PRO A 72 98.16 -52.30 REMARK 500 SER A 106 -17.09 -153.01 REMARK 500 THR A 127 17.28 -141.16 REMARK 500 ASP A 156 43.94 -150.75 REMARK 500 ASP A 175 71.41 60.99 REMARK 500 ALA A 193 136.22 66.45 REMARK 500 MET A 208 47.57 -95.94 REMARK 500 ASP A 210 -152.29 -148.52 REMARK 500 HIS A 234 72.11 -107.17 REMARK 500 ARG B 47 136.24 65.93 REMARK 500 SER B 51 -164.99 -175.73 REMARK 500 ILE B 59 32.32 -87.63 REMARK 500 LEU B 124 32.87 -77.66 REMARK 500 ASP B 175 75.35 53.79 REMARK 500 ALA B 193 170.81 71.34 REMARK 500 ASP B 210 -156.72 -125.46 REMARK 500 ARG B 228 54.51 39.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 336 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 337 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 338 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 339 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 340 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 341 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 336 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 337 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 338 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2PVR RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN AN ACTIVE CONFORMATION REMARK 900 RELATED ID: 2RKP RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR DRB REMARK 900 RELATED ID: 1JWH RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEX WITH THE CATALYTIC SUBUNIT CK2BETA (CK2 REMARK 900 HOLOENZYME) REMARK 900 RELATED ID: 1LP4 RELATED DB: PDB REMARK 900 THE HOMOLOGUOUS PROTEIN FROM ZEA MAYS IN COMPLEX WITH AMPPNP AND REMARK 900 MAGNESIUM IONS DBREF 3FWQ A 1 335 UNP P68400 CSK21_HUMAN 1 335 DBREF 3FWQ B 1 335 UNP P68400 CSK21_HUMAN 1 335 SEQRES 1 A 335 MET SER GLY PRO VAL PRO SER ARG ALA ARG VAL TYR THR SEQRES 2 A 335 ASP VAL ASN THR HIS ARG PRO ARG GLU TYR TRP ASP TYR SEQRES 3 A 335 GLU SER HIS VAL VAL GLU TRP GLY ASN GLN ASP ASP TYR SEQRES 4 A 335 GLN LEU VAL ARG LYS LEU GLY ARG GLY LYS TYR SER GLU SEQRES 5 A 335 VAL PHE GLU ALA ILE ASN ILE THR ASN ASN GLU LYS VAL SEQRES 6 A 335 VAL VAL LYS ILE LEU LYS PRO VAL LYS LYS LYS LYS ILE SEQRES 7 A 335 LYS ARG GLU ILE LYS ILE LEU GLU ASN LEU ARG GLY GLY SEQRES 8 A 335 PRO ASN ILE ILE THR LEU ALA ASP ILE VAL LYS ASP PRO SEQRES 9 A 335 VAL SER ARG THR PRO ALA LEU VAL PHE GLU HIS VAL ASN SEQRES 10 A 335 ASN THR ASP PHE LYS GLN LEU TYR GLN THR LEU THR ASP SEQRES 11 A 335 TYR ASP ILE ARG PHE TYR MET TYR GLU ILE LEU LYS ALA SEQRES 12 A 335 LEU ASP TYR CYS HIS SER MET GLY ILE MET HIS ARG ASP SEQRES 13 A 335 VAL LYS PRO HIS ASN VAL MET ILE ASP HIS GLU HIS ARG SEQRES 14 A 335 LYS LEU ARG LEU ILE ASP TRP GLY LEU ALA GLU PHE TYR SEQRES 15 A 335 HIS PRO GLY GLN GLU TYR ASN VAL ARG VAL ALA SER ARG SEQRES 16 A 335 TYR PHE LYS GLY PRO GLU LEU LEU VAL ASP TYR GLN MET SEQRES 17 A 335 TYR ASP TYR SER LEU ASP MET TRP SER LEU GLY CYS MET SEQRES 18 A 335 LEU ALA SER MET ILE PHE ARG LYS GLU PRO PHE PHE HIS SEQRES 19 A 335 GLY HIS ASP ASN TYR ASP GLN LEU VAL ARG ILE ALA LYS SEQRES 20 A 335 VAL LEU GLY THR GLU ASP LEU TYR ASP TYR ILE ASP LYS SEQRES 21 A 335 TYR ASN ILE GLU LEU ASP PRO ARG PHE ASN ASP ILE LEU SEQRES 22 A 335 GLY ARG HIS SER ARG LYS ARG TRP GLU ARG PHE VAL HIS SEQRES 23 A 335 SER GLU ASN GLN HIS LEU VAL SER PRO GLU ALA LEU ASP SEQRES 24 A 335 PHE LEU ASP LYS LEU LEU ARG TYR ASP HIS GLN SER ARG SEQRES 25 A 335 LEU THR ALA ARG GLU ALA MET GLU HIS PRO TYR PHE TYR SEQRES 26 A 335 THR VAL VAL LYS ASP GLN ALA ARG MET GLY SEQRES 1 B 335 MET SER GLY PRO VAL PRO SER ARG ALA ARG VAL TYR THR SEQRES 2 B 335 ASP VAL ASN THR HIS ARG PRO ARG GLU TYR TRP ASP TYR SEQRES 3 B 335 GLU SER HIS VAL VAL GLU TRP GLY ASN GLN ASP ASP TYR SEQRES 4 B 335 GLN LEU VAL ARG LYS LEU GLY ARG GLY LYS TYR SER GLU SEQRES 5 B 335 VAL PHE GLU ALA ILE ASN ILE THR ASN ASN GLU LYS VAL SEQRES 6 B 335 VAL VAL LYS ILE LEU LYS PRO VAL LYS LYS LYS LYS ILE SEQRES 7 B 335 LYS ARG GLU ILE LYS ILE LEU GLU ASN LEU ARG GLY GLY SEQRES 8 B 335 PRO ASN ILE ILE THR LEU ALA ASP ILE VAL LYS ASP PRO SEQRES 9 B 335 VAL SER ARG THR PRO ALA LEU VAL PHE GLU HIS VAL ASN SEQRES 10 B 335 ASN THR ASP PHE LYS GLN LEU TYR GLN THR LEU THR ASP SEQRES 11 B 335 TYR ASP ILE ARG PHE TYR MET TYR GLU ILE LEU LYS ALA SEQRES 12 B 335 LEU ASP TYR CYS HIS SER MET GLY ILE MET HIS ARG ASP SEQRES 13 B 335 VAL LYS PRO HIS ASN VAL MET ILE ASP HIS GLU HIS ARG SEQRES 14 B 335 LYS LEU ARG LEU ILE ASP TRP GLY LEU ALA GLU PHE TYR SEQRES 15 B 335 HIS PRO GLY GLN GLU TYR ASN VAL ARG VAL ALA SER ARG SEQRES 16 B 335 TYR PHE LYS GLY PRO GLU LEU LEU VAL ASP TYR GLN MET SEQRES 17 B 335 TYR ASP TYR SER LEU ASP MET TRP SER LEU GLY CYS MET SEQRES 18 B 335 LEU ALA SER MET ILE PHE ARG LYS GLU PRO PHE PHE HIS SEQRES 19 B 335 GLY HIS ASP ASN TYR ASP GLN LEU VAL ARG ILE ALA LYS SEQRES 20 B 335 VAL LEU GLY THR GLU ASP LEU TYR ASP TYR ILE ASP LYS SEQRES 21 B 335 TYR ASN ILE GLU LEU ASP PRO ARG PHE ASN ASP ILE LEU SEQRES 22 B 335 GLY ARG HIS SER ARG LYS ARG TRP GLU ARG PHE VAL HIS SEQRES 23 B 335 SER GLU ASN GLN HIS LEU VAL SER PRO GLU ALA LEU ASP SEQRES 24 B 335 PHE LEU ASP LYS LEU LEU ARG TYR ASP HIS GLN SER ARG SEQRES 25 B 335 LEU THR ALA ARG GLU ALA MET GLU HIS PRO TYR PHE TYR SEQRES 26 B 335 THR VAL VAL LYS ASP GLN ALA ARG MET GLY HET GOL A 336 6 HET GOL A 337 6 HET SO4 A 338 5 HET CL A 339 1 HET CL A 340 1 HET CL A 341 1 HET GOL B 336 6 HET CL B 337 1 HET CL B 338 1 HETNAM GOL GLYCEROL HETNAM SO4 SULFATE ION HETNAM CL CHLORIDE ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 GOL 3(C3 H8 O3) FORMUL 5 SO4 O4 S 2- FORMUL 6 CL 5(CL 1-) FORMUL 12 HOH *204(H2 O) HELIX 1 1 PRO A 20 TRP A 24 5 5 HELIX 2 2 ASP A 25 HIS A 29 5 5 HELIX 3 3 ASN A 35 ASP A 37 5 3 HELIX 4 4 LYS A 74 ARG A 89 1 16 HELIX 5 5 THR A 129 MET A 150 1 22 HELIX 6 6 LYS A 158 HIS A 160 5 3 HELIX 7 7 SER A 194 LYS A 198 5 5 HELIX 8 8 GLY A 199 VAL A 204 1 6 HELIX 9 9 TYR A 211 ARG A 228 1 18 HELIX 10 10 ASP A 237 GLY A 250 1 14 HELIX 11 11 THR A 251 TYR A 261 1 11 HELIX 12 12 ASP A 266 GLY A 274 1 9 HELIX 13 13 ARG A 280 PHE A 284 5 5 HELIX 14 14 ASN A 289 VAL A 293 5 5 HELIX 15 15 SER A 294 LYS A 303 1 10 HELIX 16 16 ASP A 308 ARG A 312 5 5 HELIX 17 17 THR A 314 GLU A 320 1 7 HELIX 18 18 HIS A 321 TYR A 325 5 5 HELIX 19 19 THR A 326 ASP A 330 5 5 HELIX 20 20 PRO B 20 ASP B 25 1 6 HELIX 21 21 TYR B 26 HIS B 29 5 4 HELIX 22 22 ASN B 35 ASP B 37 5 3 HELIX 23 23 LYS B 74 ARG B 89 1 16 HELIX 24 24 LYS B 122 GLN B 126 5 5 HELIX 25 25 THR B 129 MET B 150 1 22 HELIX 26 26 LYS B 158 HIS B 160 5 3 HELIX 27 27 SER B 194 LYS B 198 5 5 HELIX 28 28 GLY B 199 VAL B 204 1 6 HELIX 29 29 TYR B 211 PHE B 227 1 17 HELIX 30 30 ASP B 237 GLY B 250 1 14 HELIX 31 31 GLY B 250 TYR B 261 1 12 HELIX 32 32 ASP B 266 GLY B 274 1 9 HELIX 33 33 ARG B 280 VAL B 285 5 6 HELIX 34 34 SER B 294 LEU B 305 1 12 HELIX 35 35 THR B 314 HIS B 321 1 8 HELIX 36 36 PRO B 322 TYR B 325 5 4 HELIX 37 37 THR B 326 ASP B 330 5 5 SHEET 1 A 5 TYR A 39 LYS A 44 0 SHEET 2 A 5 GLU A 52 ASN A 58 -1 O GLU A 55 N VAL A 42 SHEET 3 A 5 LYS A 64 ILE A 69 -1 O VAL A 65 N ALA A 56 SHEET 4 A 5 PRO A 109 PHE A 113 -1 O PHE A 113 N VAL A 66 SHEET 5 A 5 LEU A 97 LYS A 102 -1 N VAL A 101 O ALA A 110 SHEET 1 B 2 ILE A 152 MET A 153 0 SHEET 2 B 2 GLU A 180 PHE A 181 -1 O GLU A 180 N MET A 153 SHEET 1 C 2 VAL A 162 ASP A 165 0 SHEET 2 C 2 LYS A 170 LEU A 173 -1 O LYS A 170 N ASP A 165 SHEET 1 D 5 TYR B 39 GLY B 46 0 SHEET 2 D 5 SER B 51 ASN B 58 -1 O VAL B 53 N LEU B 45 SHEET 3 D 5 GLU B 63 LEU B 70 -1 O VAL B 65 N ALA B 56 SHEET 4 D 5 PRO B 109 GLU B 114 -1 O LEU B 111 N LYS B 68 SHEET 5 D 5 LEU B 97 LYS B 102 -1 N VAL B 101 O ALA B 110 SHEET 1 E 2 ILE B 152 MET B 153 0 SHEET 2 E 2 GLU B 180 PHE B 181 -1 O GLU B 180 N MET B 153 SHEET 1 F 2 VAL B 162 ASP B 165 0 SHEET 2 F 2 LYS B 170 LEU B 173 -1 O ARG B 172 N MET B 163 CISPEP 1 GLU A 230 PRO A 231 0 -6.04 CISPEP 2 GLU B 230 PRO B 231 0 -1.83 SITE 1 AC1 6 ARG A 21 GLU A 22 GLN A 40 LEU A 41 SITE 2 AC1 6 ASP A 103 HOH A 364 SITE 1 AC2 4 ARG A 306 TYR A 307 ASP A 308 SER A 311 SITE 1 AC3 6 ARG A 80 ARG A 155 GLU A 180 TYR A 188 SITE 2 AC3 6 ASN A 189 HOH A 498 SITE 1 AC4 3 HIS A 148 ALA A 315 HOH A 399 SITE 1 AC5 4 LYS A 68 ILE A 174 ASP A 175 HOH A 343 SITE 1 AC6 5 SER A 7 TYR A 182 PRO A 184 GLY A 185 SITE 2 AC6 5 MET A 208 SITE 1 AC7 5 ASP B 253 ARG B 278 ARG B 306 TYR B 307 SITE 2 AC7 5 ASP B 308 SITE 1 AC8 3 VAL B 11 HIS B 148 ALA B 315 SITE 1 AC9 3 LYS B 122 PRO B 159 HIS B 160 CRYST1 71.324 71.324 125.681 90.00 90.00 90.00 P 43 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014021 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014021 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007957 0.00000